Skip to main content
OpenTrials

Clinical trial condition

Prostatic Neoplasms

Explore clinical trials studying Prostatic Neoplasms. Study availability and eligibility vary by location and protocol.

4,810 public trials 982 recruiting studies
Refine in advanced search Browse all conditions

Prostatic Neoplasms trial results

Recruiting

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

NCT06780670

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • VA Greater LA Healthcare System Los Angeles, California, United States
  • VA Palo Alto Health Care System Palo Alto, California, United States
  • Stanford University Medical Center Palo Alto, California, United States
  • Sansum Clinic Santa Barbara, California, United States
View all 93 locations
View Trial Details
Recruiting

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

NCT07213674

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • City of Hope Cancer Center Phoenix Goodyear, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope Orange County Lennar Foundation Cancer Center Duarte, California, United States
  • Providence Saint Jude Medical Center Fullerton, California, United States
View all 156 locations
View Trial Details
Recruiting

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

NCT06855277

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Urology Centers Of Alabama Pc Homewood, Alabama, United States
  • Stanford University Medical Center Palo Alto, California, United States
  • Sansum Clinic Santa Barbara, California, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
View all 100 locations
View Trial Details
Recruiting

A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer

NCT07570979

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Mary Crowley Cancer Research Dallas, Texas, United States
  • Novartis Investigative Site Melbourne, Victoria, Australia
  • Novartis Investigative Site Hirakata, Osaka, Japan
  • Novartis Investigative Site Montreal, Quebec, Canada
View Trial Details
Recruiting

Precision-Based Genomics in Prostate Cancer

NCT04706663

Conditions
Disease Attributes, Disease Susceptibility, Genetic Predisposition to Disease, +13 more
Locations
  • University of California San Diego La Jolla, California, United States
  • University of California San Francisco San Francisco, California, United States
  • NorthShore University HealthSystem Evanston, Illinois, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details

Related conditions